These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37503233)

  • 1. The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database.
    Rothschild HT; Clelland EN; Abel MK; Chien AJ; Shui AM; Esserman L; Khan SA; Mukhtar RA
    Res Sq; 2023 Jul; ():. PubMed ID: 37503233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB).
    Rothschild HT; Clelland EN; Abel MK; Chien AJ; Shui AM; Esserman L; Khan SA; Mukhtar RA
    Breast Cancer Res Treat; 2024 Jan; 203(2):245-256. PubMed ID: 37833450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study.
    Magnoni F; Corso G; Maisonneuve P; Bianchi B; Accardo G; Sangalli C; Massari G; Rotili A; Nicosia L; Pesapane F; Montagna E; Mazzarol G; Galimberti V; Veronesi P; Curigliano G
    EClinicalMedicine; 2024 May; 71():102552. PubMed ID: 38545425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 taiwan cancer registry index cases.
    Chen BF; Tsai YF; Lien PJ; Lin YS; Feng CJ; Chen YJ; Cheng HF; Tseng LM; Huang CC
    Breast Cancer Res Treat; 2023 Oct; 201(3):547-560. PubMed ID: 37470893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive Lobular Carcinoma Has Worse Outcome Compared with Invasive Ductal Carcinoma in Stage IV Breast Cancer with Bone-Only Metastasis.
    Luo Y; Ma A; Huang S; Yu Y
    Breast Care (Basel); 2022 Jun; 17(3):296-305. PubMed ID: 35949419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of lobular versus ductal histology on overall survival in metastatic breast cancer: a French retrospective multicentre cohort study.
    Dalenc F; Lusque A; De La Motte Rouge T; Pistilli B; Brain E; Pasquier D; Debled M; Thery JC; Gonçalves A; Desmoulins I; Levy C; Uwer L; Ferrero JM; Eymard JC; Mouret-Reynier MA; Patsouris A; Frenel JS; Petit T; Chevrot M; Bachelot T; Guiu S
    Eur J Cancer; 2022 Mar; 164():70-79. PubMed ID: 35176614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis.
    Makower D; Qin J; Lin J; Xue X; Sparano JA
    NPJ Breast Cancer; 2022 Jan; 8(1):4. PubMed ID: 35027533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Surgical Outcomes Between Estrogen Receptor Positive Invasive Lobular and Invasive Ductal Carcinoma of the Breast-A Propensity Matched Analysis.
    O'Connor DJ; Davey MG; McFeetors C; McLaughlin RP; Sweeney KJ; Barry MK; Malone CM; Wahab SAE; Lowery AJ; Kerin MJ
    Clin Breast Cancer; 2024 Dec; 24(8):e655-e662. PubMed ID: 39127596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis.
    Weiser R; Polychronopoulou E; Hatch SS; Haque W; Ghani HA; He J; Kuo YF; Gradishar WJ; Klimberg VS
    Cancer; 2022 May; 128(9):1738-1747. PubMed ID: 35137951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
    Pramod N; Nigam A; Basree M; Mawalkar R; Mehra S; Shinde N; Tozbikian G; Williams N; Majumder S; Ramaswamy B
    Oncologist; 2021 Jun; 26(6):e943-e953. PubMed ID: 33641217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.
    Arps DP; Healy P; Zhao L; Kleer CG; Pang JC
    Breast Cancer Res Treat; 2013 Apr; 138(3):719-26. PubMed ID: 23535842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
    Braunstein LZ; Brock JE; Chen YH; Truong L; Russo AL; Arvold ND; Harris JR
    Breast Cancer Res Treat; 2015 Jan; 149(2):555-64. PubMed ID: 25604797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Stage Breast Cancer: Does Histologic Subtype (Ductal vs. Lobular) Impact 5 Year Overall Survival?
    Mubarak F; Kowkabany G; Popp R; Bansal S; Ahmed SH; Sharan S; Sukniam KB; Raikot SR; Jimenez PB; Popp K; Manaise HK; Gabriel E
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of pleomorphic lobular carcinoma versus invasive lobular carcinoma.
    Haque W; Arms A; Verma V; Hatch S; Brian Butler E; Teh BS
    Breast; 2019 Feb; 43():67-73. PubMed ID: 30496936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?
    Mamtani A; Grabenstetter A; Sevilimedu V; Morrow M; Gemignani ML
    Breast Cancer Res Treat; 2023 Jan; 197(2):417-423. PubMed ID: 36394689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.